Idea Density in Exam Performance
IDEP
Impact of Reduced Idea Density on Pharmacy Students' Attainment in Pharmaceutical Calculations: a Single-blind Multicentre Randomised Controlled Trial
1 other identifier
interventional
204
1 country
1
Brief Summary
Text can be written in multiple ways to mean the same thing; changing how a text is written can make it easier or harder to understand. How many concepts or ideas there are in a text, divided by the total number of words, is one possible way to determine how easy or hard it is to understand. This ratio is called idea density (ID). Varying ID has been shown to affect the speed at which a reader understands; it impacts certain people more than others, such as second language speakers. This effect may be of particular importance in an exam, where understanding a question in a limited time is key. In the UK, pharmacy students must undertake an exam set by the General Pharmaceutical Council (GPhC) to be registered as pharmacists. The exam involves pharmaceutical calculations and shows variable pass rates. This study aims to evaluate the impact of reducing ID in a pharmaceutical calculation test and will be conducted in 14 schools of pharmacy in the UK. All participants will take a GPhC style test. Then, participants will be divided into two groups of equal size; one group will undertake a second test with the same ID as the first, while the second group will undertake a test with a lower ID. Finally, the investigators will compare the second test scores between the two groups as cohorts and question by question, evaluating whether lowering ID has increased students' scores. If and effect is seen, ensuring that questions are written with a controlled ID may help ensure we are examining more fairly and allowing students with the requisite knowledge to pass.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 31, 2022
CompletedFirst Posted
Study publicly available on registry
September 2, 2022
CompletedStudy Start
First participant enrolled
October 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2022
CompletedOctober 10, 2023
October 1, 2023
1 month
August 31, 2022
October 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall performance on test 2
The primary outcome is the performance in the second calculation test 2. Overall score per student can be between 0-12, and performance of all students on each question a decimal percent between 0-1, with 0 meaning 0% of students answered correctly and 1 meaning 100% of students answered correctly.
1 month
Secondary Outcomes (2)
Pass rate
1 month
Demographic
1 month
Study Arms (2)
Control
NO INTERVENTIONParticipants in the control group will receive an initial 12 question baseline test (same as intervention). They will after two weeks receive a second test that is linguistically the same as the national GPhC exam.
Intervention
EXPERIMENTALParticipants in the intervention group will receive an initial 12 question baseline test (same as control). They will after two weeks receive a second test that is reduced in idea density by around 10% overall.
Interventions
Question idea density reduced (ratio of propositions to total words used).
Eligibility Criteria
You may qualify if:
- Over 18 years of age
- Registered as a student on an MPharm course in the UK
- Be in years 1-4 of the course (levels 1-7)
You may not qualify if:
- Under 18
- Not registered on an MPharm course in the UK
- Are currently undertaking a foundation year (level 3)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Liverpool John Moores Universitylead
- University of Central Lancashirecollaborator
- Aston Universitycollaborator
- University of Birminghamcollaborator
- University of Bradfordcollaborator
- De Montfort Universitycollaborator
- University of Greenwichcollaborator
- University of Huddersfieldcollaborator
- Kingston Universitycollaborator
- Newcastle Universitycollaborator
- Queen's University, Belfastcollaborator
- Robert Gordon Universitycollaborator
- University of Ulstercollaborator
- University of Wolverhamptoncollaborator
Study Sites (1)
Liverpool John Moores University
Liverpool, Merseyside, L3 3AF, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Students will be blinded to allocation; performed using sequentially generated random numbers. The control and intervention exams will be identical in all but the idea density of the questions. The students are the unit of randomisation and intervention. As the randomisation will be 1:1, the block size multiplier will be 2, 4, 6 and the block size 4, 8, and 12. This approach will reduce bias and balance allocating participants to the treatment arm. Furthermore, the process will adopt block permutation, meaning that treatment assignments within blocks are determined to be random in order but that the desired allocation proportions are achieved exactly within each block. A computerised random number generator will generate the sequence
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer in Clinical Pharmacy
Study Record Dates
First Submitted
August 31, 2022
First Posted
September 2, 2022
Study Start
October 3, 2022
Primary Completion
November 6, 2022
Study Completion
December 6, 2022
Last Updated
October 10, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Within 1 year of study (when published), indefinitely available on university repository
Study protocol to be published Original (anonymised) data to be placed on university repository